HK Stock Market Move | "The first AI intelligent agent stock in corporate decision-making, DEEPZERO (02723), rose more than 10%. Institutions expect it to enter the Hong Kong Stock Connect."
DeepTech Intelligence (02723) rose over 10%. As of the time of writing, it is up 8.83%, priced at HKD 653, with a trading volume of HKD 81,987,300.
DEEPZERO (02723) has risen over 10%, and as of the time of writing, it is up 8.83% at HKD 653, with a transaction volume of HKD 81.9873 million.
On the news front, Hang Seng Index Company is expected to announce the semi-annual index adjustment results on August 25, 2026, with changes to be implemented after the market closes on September 4 and effective from September 7. According to Huatai, DEEPZERO is likely to enter the Hong Kong Stock Connect. In May of this year, DEEPZERO officially listed its shares, becoming the first "enterprise decision-making AI intelligent entity" on the Hong Kong stock market. The companys core products, AlphaDesk/AlphaData, have a net revenue retention rate of over 85%/80%, with clients primarily consisting of large and medium-sized enterprises.
Furthermore, FDE is becoming a key infrastructure for the enterprise-level application of AI. DEEPZEROs founder and CEO, Huang Xiaonan, believes that DEEPZERO's similarities with Palantir lie in the methodology of implementing enterprise-level AI: first, there must be someone who understands the client's true business pain points; second, there must be product capabilities; and third, there must be an implementation and delivery team to genuinely embed AI products into the client's processin the context of Palantir, this role corresponds to FDE, which DEEPZERO internally refers to as the AI product manager/solutions team.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) invested 6.794 million yuan on August 12 to repurchase 125,000 shares of A-shares.

CKI HOLDINGS (01038) reported its interim results, with shareholders attributable profit of HKD 21.252 billion, an increase of 388.78% year-on-year.

NEP INTERLONG (08329) issues a profit warning, expecting a mid-term net profit of approximately 7 million yuan.
Jiangsu Hengrui Pharmaceuticals (01276) invested 6.794 million yuan on August 12 to repurchase 125,000 shares of A-shares.

CKI HOLDINGS (01038) reported its interim results, with shareholders attributable profit of HKD 21.252 billion, an increase of 388.78% year-on-year.

NEP INTERLONG (08329) issues a profit warning, expecting a mid-term net profit of approximately 7 million yuan.

RECOMMEND





